May 21-22, 2025
London,UK
Welcome to the 3rd World Congress on Stroke and Neurological Disorders, scheduled for May 21-22, 2025, in the dynamic city of London, UK. We are delighted to bring together an exceptional assembly of stroke neurologists, researchers, clinicians, and healthcare experts from around the world. This event will showcase pioneering research, innovative techniques, and the latest advancements in stroke and neurological disorder care.
The congress serves as an essential hub for collaboration, knowledge exchange, and exploring the forefront of stroke prevention, acute care, neurorehabilitation, and recovery.
London, a city celebrated for its rich history and contemporary charm, provides the perfect setting for this gathering. We encourage you to immerse yourself in its vibrant culture, outstanding hospitality, and iconic landmarks.
Thank you for joining us in our collective effort to enhance the understanding and management of stroke and neurological disorders. We anticipate a highly engaging and productive conference, fostering meaningful discussions on stroke treatment, prevention strategies, advancements in neuroimaging, and cutting-edge neuro interventions.
Best regards,
Ava Rae
Program Manager
Organizing Committee stroke 2025
Email: strokecongress@pulsusgather.com
WhatsApp: +44 7389 644903
About the 3rd World Congress on Stroke and Neurological Disorders
Make sure to mark your calendar for the 3rd World Congress on Stroke and Neurological Disorders, which will take place on May 21-22, 2025, in the vibrant city of London, UK. This prestigious global event will gather neurologists, researchers, healthcare professionals, and neuroscientists to discuss groundbreaking research, share knowledge, and explore the latest advancements in neurology.
Focusing on stroke and other neurological conditions, the conference will offer a comprehensive platform to explore cutting-edge technologies, the latest treatment methods, and significant breakthroughs in the field. Attendees will engage in thought-provoking discussions, attend keynote speeches, and participate in workshops and poster sessions
Conference Features
Conference will cover are:
Renowned experts and leading professionals from the field will present their pioneering research and share invaluable insights, making this a must-attend event for anyone passionate about advancing neurological science and patient care.
Networking and Cultural Experience
Make sure to mark your calendar for the 3rd World Congress on Stroke and Neurological Disorders, which will take place on May 21-22, 2025, in the vibrant city of London, UK. This prestigious global event will gather neurologists, researchers, healthcare professionals, and neuroscientists to discuss ground breaking research, share knowledge, and explore the latest advancements in neurology.
Focusing on stroke and other neurological conditions, the conference will offer a comprehensive platform to explore cutting-edge technologies, the latest treatment methods, and significant breakthroughs in the field. Attendees will engage in thought-provoking discussions, attend keynote speeches, and participate in workshops and poster sessions
Target Audience for Stroke 2025
The Stroke 2025 Conference welcomes a diverse group of professionals and stakeholders, including:
Highlights of Stroke 2025 Conference
Join us at Stroke 2025 and contribute to the global effort to revolutionize stroke prevention, treatment, and care.
We are thrilled to announce that abstract submissions are now open for Stroke 2025. This is a fantastic opportunity to present your latest research, clinical insights, and advancements in stroke care and neurological disorders.
Submission Categories:
We welcome abstracts in a variety of formats, allowing you to present your work in a way that best suits your research:
How to Submit:
Important Deadlines:
We look forward to your contributions to advancing stroke research and care at Stroke 2025.
Track 1: Neurodegenerative Diseases and Stress
Neurodegenerative diseases affect millions of individuals globally, leading to the gradual loss of function and eventual death of nerve cells in the brain and peripheral nervous system. Chronic stress has been identified as a significant contributor to an imbalanced stress response, which can elevate the risk of developing neurodegenerative disorders such as Alzheimer’s disease (AD). Studies in epidemiology reveal that prolonged exposure to stress—whether from daily challenges, work pressures, traumatic experiences, or other life events—increases the likelihood of dementia-related conditions like AD.
Track 2: Neurological Disorders and Stroke
Neurological disorders impact both the central and peripheral nervous systems. Stroke, a leading cause of disability worldwide, has often been overlooked as a brain-related condition due to its classification as a cardiovascular disease by the World Health Organization (WHO). However, in the latest revision of the WHO International Classification of Diseases (ICD-11), stroke is now categorized as a neurological disorder. This reclassification underscores the role of neurologists in treating stroke and highlights the profound neurological consequences stroke survivors face. This shift is expected to improve awareness, drive increased research funding, and enhance care for stroke patients.
Track 3: Clinical Neurophysiology
Clinical neurophysiology examines the bioelectrical activity of the central and peripheral nervous systems, encompassing both spontaneous and induced processes. This field bridges the study of pathophysiology and the development of diagnostic methods for disorders affecting these systems. It serves as a continuation of a neurology consultation, with tests often extending beyond laboratory settings. Stroke remains the third leading cause of death globally and the primary cause of acquired neurological disabilities. In ischemic strokes, a cascade of events triggered by excitotoxicity leads to tissue damage shortly after the onset of impaired blood flow.
Track 4: Neuropsychology and Addiction
Addiction, derived from the Latin term addicere meaning "to enslave," is marked by a perceived loss of control over one’s behavior. Individuals with addictions often continue substance abuse despite being aware of its harmful consequences, reflecting impairments in decision-making, affect regulation, and inhibitory control. Neuroimaging studies in substance-abusing populations have consistently identified deficits in the frontal cortical networks, which are critical for self-regulation and decision-making.
Track 5: Alzheimer’s and Parkinson’s Diseases
Alzheimer’s disease is a progressive condition that impairs memory, cognitive abilities, and basic daily functions. Symptoms typically manifest later in life, primarily affecting individuals aged 65 and older. Experts estimate that over six million Americans may suffer from dementia caused by Alzheimer’s, making it one of the leading causes of death in the U.S. While previously ranked as the sixth leading cause of mortality, recent studies suggest Alzheimer’s may now rank third, following heart disease and cancer, as a primary cause of death among the elderly.
Neuroimmunology merges the fields of neurology, which focuses on the nervous system, and immunology, which examines the immune system. This discipline explores the interaction between these two complex systems throughout development, maintenance of balance, and responses to injury. A key objective of this growing area of research is to deepen our understanding of the causes of certain neurological diseases, many of which remain unexplained. Neuroimmunology is pivotal in developing new pharmacological treatments for various neurological conditions, advancing both diagnosis and therapeutic options.
Neuropharmacology is the study of how drugs affect cellular functions in the nervous system and the mechanisms by which these effects influence behavior. This field is divided into two main branches: behavioral and molecular neuropharmacology. Behavioral neuropharmacology focuses on the influence of drugs on human behavior, including the effects of drug addiction and dependency on the brain. Molecular neuropharmacology, on the other hand, studies the interactions between neurons and neurochemicals, with the goal of discovering medications that enhance neurological function. Neurochemistry, closely related to this field, examines the chemicals that regulate and influence the physiology of the nervous system.
A head injury involves any damage to the brain, skull, or scalp, and can range from a minor bump to a serious trauma. Traumatic brain injuries (TBI) can result from concussions, skull fractures, or scalp wounds, and the consequences depend on the nature and severity of the injury. TBI, which is caused by an external mechanical force, can lead to temporary or permanent cognitive, physical, and psychological impairments, including altered levels of consciousness. Behavioral neuroscience is the study of the biological underpinnings of behavior in both humans and animals, providing insights into how brain injuries can affect behavior and cognitive functions.
Cognitive neuroscience explores how the brain facilitates mental processes. It examines how networks of neurons work together to form the complex structures of the human brain. Cognitive neuroscience links higher-level cognitive functions, such as thinking, memory, and language, to specific brain regions and neuronal mechanisms. It integrates techniques from cognitive psychology and artificial intelligence to create models of cognition. Cognitive psychology, a closely related field, investigates mental processes such as perception, attention, problem-solving, learning, and memory, offering insights into how individuals think and interact with the world around them.
Neurobiology investigates the biological mechanisms by which the nervous system influences behavior, serving as the bridge between genetic predispositions and environmental factors. The brain acts as the interface between inherited traits and the experiences shaped by one’s environment. Neurobiological mechanisms, regulated by both genetic and environmental factors, play a crucial role in shaping behaviors. Much of neurobiology has focused on understanding the structure and function of nerve cells (neurons) and glial cells, as well as the synapses that connect them, forming the foundation of brain function and behavior.
Neurosurgery, also referred to as neurological surgery, is a medical specialty dedicated to the prevention, diagnosis, and treatment of disorders affecting the brain, spine, and nervous system. This surgical field addresses conditions such as brain tumors, spinal cord abnormalities, and nerve root dysfunction. Back pain resulting from nerve root issues can cause symptoms like numbness, muscle weakness, and impaired bowel and bladder control, signaling the need for surgical intervention. Procedures like discectomy, laminectomy, and spinal fusion are commonly used to alleviate severe back pain. However, neurosurgery carries risks, including potential nerve damage and infections, which may lead to paralysis.
Track 12 : Pediatric Neurology and Epilepsy
Pediatric neurology (PN) is dedicated to the diagnosis, treatment, and research of neurological conditions affecting children, from fetal development to adulthood. Pediatric neurologists, or child neurologists, specialize in identifying and managing disorders of the central and peripheral nervous systems in children. These disorders may involve the brain, spinal cord, nerves, or muscles, and can result in various issues such as seizures, migraines, and developmental delays. Pediatric neurologists work with patients from infancy through young adulthood, providing ongoing care and treatment.
Molecular genetics involves using recombinant DNA techniques to alter genetic material within various organisms, including plants, animals, and microorganisms. This field enables scientists to pinpoint genes responsible for specific brain functions. Human cells contain approximately 30,000 to 60,000 genes, as detailed by the Human Genome Project. Neurons, however, are unique in the genes they express compared to other cell types. Neurobiology, a branch of both biology and neuroscience, focuses on understanding how nervous system cells form functional circuits that process information and influence behavior. While neurobiology is a more specific field, neuroscience encompasses the broader scientific study of the nervous system, including the brain and spinal cord.
Central nervous system (CNS) injuries, such as stroke, traumatic brain injury, and spinal cord damage, are critical events that can lead to significant disability and death. Early brain injury following stroke or trauma is a major contributor to poor outcomes and mortality. The mechanisms of early brain injury are complex and not yet fully understood. Neuronal cell death in the acute phase of CNS injury plays a key role in long-term neurological deficits and prognosis. Despite advances in understanding the inflammatory responses and adult neurogenesis, repairing the brain remains challenging. The harsh environment following injury, coupled with the lack of support for neural cell regeneration, complicates efforts to achieve functional recovery.
Molecular biology is the study of biological processes at the molecular level, particularly how DNA, RNA, and proteins interact and regulate cellular functions. This field intersects with genetics and biochemistry, providing insights into how cells function and communicate. Cell biology, a related field, explores the structure and function of cells, including both single-celled organisms like bacteria and the complex cells of multicellular organisms like humans. The central concept of cell biology is that cells are the fundamental units of life, responsible for all biological activities within an organism.
Track 16: Molecular Neuroscience and Neurodegeneration
Neuroscience is inherently interdisciplinary in its quest to understand the brain. Molecular neuroscience, a subfield of neuroscience, utilizes techniques from molecular biology, molecular genetics, protein chemistry, and other disciplines to explore the biology of the nervous system. Much of modern molecular and cellular neuroscience is focused on translational research, which aims to bridge laboratory findings with clinical applications, particularly in the development of tools for systems neuroscience. This shift in focus means that biological processes are increasingly viewed through the lens of disease-related events, with molecules considered primarily as potential therapeutic targets, leaving fewer fundamental questions about brain function being explored.
Track 17: Neuroscience and Artificial Intelligence
Artificial intelligence (AI) is becoming an invaluable tool in neuroscience, helping researchers to better understand brain function and advancing the field itself. Neuroscience has long influenced the development of AI, serving as a model for creating systems that mimic human-like intelligence. There are two main ways neuroscience informs AI: by developing neural networks that replicate the structure of the brain and by emulating human intelligence. The rise of more powerful processors and the availability of large datasets have significantly contributed to the success of AI, which in turn supports the progression of neuroscience by allowing the creation of more accurate brain models and aiding in the discovery of the brain’s underlying mechanisms.
Track 18: Human Brain Mapping
Human brain mapping refers to a set of techniques in neuroscience that map biological data or features onto spatial representations of the brain, allowing researchers to study both its structure and function. This discipline uses a combination of experimental psychology, human neuroscience, and noninvasive neuroimaging to establish connections between brain structure and function. Various methods are used in brain mapping, including regional cerebral blood flow (rCBF), regional metabolic rate of glucose (rCMRglc), near infrared spectroscopy (NIRS), electroencephalography (EEG), and magnetoencephalography (MEG), all of which help to uncover how different brain regions contribute to various cognitive and physiological processes.
Track 19: Cerebral Blood Flow and Metabolism
Cerebral blood flow (CBF) is the movement of blood through the network of arteries and veins that supply the brain. In adults, CBF is typically around 750 milliliters per minute, accounting for about 15% of total cardiac output. Arteries deliver oxygenated blood, glucose, and other nutrients to the brain. In neuroimaging techniques like functional magnetic resonance imaging (fMRI) and optical imaging, CBF and the cerebral metabolic rate of oxygen (CMRo(2)) are key drivers of contrast. The relationship between CBF and CMRo(2) during cerebral activation remains a subject of debate, with some experimental findings providing conflicting results. Factors like intracranial pressure and cerebral perfusion pressure, along with the distinctions between anterior and posterior cerebral circulation, further influence brain metabolism and blood flow.
Track 20: Brain Pathology and Oncology Research
Brain pathology refers to the study of disorders affecting the brain, particularly those confined to the central nervous system. Neuropathology focuses on examining disease processes within nervous system tissue, often through surgical biopsies or autopsy. Neuropathologists, who typically work within anatomic pathology departments, collaborate closely with clinical specialties such as neurology and neurosurgery for diagnostic purposes. Given that brain disease or injury can be linked to causes of death, neuropathology has a close connection with forensic pathology. This area of study encompasses the broader field of neuropathophysiology, contributing significantly to neurological and biomedical science, with a focus on clinical neuro-oncology for diagnosing and treating brain cancers.
This report provides an overview of market trends, growth opportunities, and key stakeholders related to the conference. The global market for neurological disorders and stroke diagnostics and treatments is expanding rapidly, driven by the increasing prevalence of these conditions and the rising demand for advanced therapeutic solutions. The conference offers a vital platform for researchers, clinicians, and industry professionals to share knowledge, highlight innovations, and encourage collaboration in this dynamic and growing sector.
Key topics addressed at the conference include neurodegenerative diseases, strategies for stroke prevention and treatment, advancements in neuroimaging technologies, regenerative medicine, neurorehabilitation, and emerging therapeutic approaches. The event attracts a diverse audience, including representatives from academia, research institutions, pharmaceutical companies, medical device manufacturers, and healthcare organizations, creating an unparalleled networking environment.
The growth of the market for neurological disorder and stroke diagnostics and treatments is influenced by several factors, including an aging population, technological progress in neuroimaging, increased research funding, and heightened awareness of early diagnosis and personalized treatment approaches. The conference plays a critical role in disseminating cutting-edge research and fostering the adoption of innovative practices, contributing to the market’s overall expansion and development.
Additionally, the event provides a strategic platform for industry stakeholders to present their groundbreaking products and services, enhance brand recognition, and explore collaboration opportunities. Exhibitors and sponsors benefit from direct engagement with a specialized audience and gain critical insights into market trends.
In conclusion, the International Conference on Neurological Disorders and Stroke, hosted in Paris, France, is instrumental in promoting research, cultivating partnerships, and driving advancements in the field. The steadily growing market for diagnostics and treatments in neurological disorders and stroke presents significant opportunities for industry leaders to enhance patient outcomes and contribute to market growth.